Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ANI Pharmaceuticals Inc. logo

ANI Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

66.14
 
USD
  
0.52
  
(0.79%)
Optionable: Yes  Market Cap: 1,382 M  90-day average vol: 145,371

Previous close: 65.62  Open: 65.9  Bid: 63.8  Ask: 67.53
52 week range    
36.99   
   70.81
Peers   
JAZZ / 
LCI / 
INFI / 
CLDX / 
EVOK / 
TEVA / 
RPRX / 
NVS / 
CAH / 
Last updated: Wednesday 24th April 2024
47
MarketXLS Rank
60
Value
30
Technical
52
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ANIP Balance Sheet

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
"""debtc"""3 M116 M10 M13 M850000.0850000.0850000.0
Accounts payable3 M2 M3 M4 M9 M15 M11 M23 M29 M37 M
Accounts receivable17 M22 M46 M59 M65 M72 M96 M129 M165 M162 M
Accrued expenses10 M8 M25 M25 M33 M31 M32 M42 M65 M115 M
Accumulated depreciation & depletion-4 M-4 M-5 M-7 M-8 M-13 M-18 M-23 M-33 M-33 M
Additional paid in capital160 M164 M173 M179 M187 M201 M214 M388 M404 M514 M
Building & improvements4 M4 M4 M4 M10 M10 M12 M20 M17 M18 M
Cash and equivalents169 M155 M27 M31 M43 M62 M8 M100 M48 M221 M
CashCashEquivalentsAndShortTermInvestments169 M155 M27 M31 M43 M62 M8 M100 M48 M221 M
Common par1000.01000.01000.01000.01000.01000.01000.025 M25 M25 M
Common stock equity140 M160 M170 M175 M197 M213 M196 M359 M339 M458 M
CommonStock1000.01000.01000.01000.01000.01000.01000.01000.01000.02000.0
Construction in progress426000.02 M4 M11 M5 M3 M3 M3 M5 M8 M
Cost in excess2 M2 M2 M2 M4 M4 M4 M28 M28 M28 M
CurrentAccruedExpenses4 M6 M19 M22 M19 M16 M17 M19 M36 M58 M
CurrentDeferredAssets8 M
CurrentDeferredRevenue711000.0451000.080000.087000.0
CurrentDeferredTaxesAssets8 M
CurrentProvisions1 M3 M6 M8 M13 M17 M27 M36 M
Deferred revenues711000.0451000.080000.087000.0
DerivativeProductLiabilities7 M14 M8 M1 M
FinancialAssets11 M12 M
Finished goods1 M2 M11 M14 M11 M17 M20 M32 M28 M36 M
Float term debt107 M113 M121 M198 M67 M176 M172 M287 M286 M285 M
GoodwillAndOtherIntangibleAssets44 M68 M178 M232 M205 M184 M192 M322 M280 M237 M
Gross fixed assets (Plant Property & Equipment)9 M12 M16 M27 M46 M53 M59 M76 M76 M78 M
IncomeTaxPayable4 M2 M5 M4 M8 M
Intangibles42 M66 M176 M230 M202 M180 M189 M294 M252 M209 M
Inventories8 M13 M26 M38 M41 M48 M61 M82 M105 M111 M
InventoriesAdjustmentsAllowances-111000.0-156000.0-174000.0-350000.0-2 M-7 M-5 M-8 M-10 M
Invested capital246 M274 M290 M373 M265 M389 M368 M645 M
Land & improvements87000.087000.0160000.0160000.05 M5 M5 M6 M2 M2 M
LongTermDebtAndCapitalLeaseObligation107 M113 M121 M198 M67 M176 M172 M287 M286 M285 M
LongTermProvisions35 M12 M
Machinery furniture & equipment5 M6 M8 M12 M27 M35 M39 M47 M53 M50 M
Net fixed assets (net PP&E)5 M7 M11 M20 M38 M41 M41 M53 M43 M45 M
NetOtherUnrealizedGainLoss-3 M12 M9 M
NonCurrentDeferredAssets15 M17 M26 M23 M28 M38 M52 M68 M81 M91 M
NonCurrentDeferredLiabilities-10 M
NonCurrentDeferredTaxesAssets15 M17 M26 M23 M28 M38 M52 M68 M81 M91 M
Number of employees601.0601.0601.0601.0601.0601.0601.0601.0601.0601.0
Other current assets8 M8 M
Other equity adjustments-379000.0-5 M-11 M-3 M12 M9 M
Other fixed assets76 M
Other non-current assets5 M6 M6 M6 M6 M7 M
Other non-current liabilities625000.0496000.07 M187 M31 M1 M5 M
OtherCurrentBorrowings3 M116 M10 M13 M850000.0850000.0850000.0
OtherCurrentLiabilities61 M36 M33 M30 M
OtherPayable12 M
Payables7 M2 M6 M4 M14 M15 M15 M23 M29 M57 M
Preferred securities of subsidiary trust25 M25 M25 M
PreferredStock25 M25 M25 M
Prepaid expenses1 M3 M4 M4 M5 M5 M6 M11 M12 M17 M
Raw materials6 M11 M15 M24 M30 M38 M45 M57 M75 M72 M
Restricted cash5 M
Retained earnings-20 M-4 M-3 M-4 M11 M18 M-5 M-48 M-97 M-80 M
Short term debt3 M116 M10 M13 M850000.0850000.0850000.0
Total assets260 M285 M323 M412 M431 M457 M461 M772 M760 M904 M
Total current assets195 M193 M103 M132 M153 M188 M170 M322 M344 M520 M
Total current liabilities13 M12 M32 M39 M166 M62 M79 M88 M99 M145 M
Total equity140 M160 M170 M175 M197 M213 M196 M359 M339 M458 M
Total liabilities120 M125 M153 M237 M233 M244 M265 M413 M422 M447 M
Total non-current assets65 M93 M220 M281 M278 M269 M291 M450 M416 M385 M
Total non-current liabilities107 M113 M121 M198 M68 M182 M187 M325 M322 M301 M
TotalEquityGrossMinority140 M160 M170 M175 M197 M213 M196 M359 M339 M458 M
TotalEquityGrossMinorityInterest140 M160 M170 M175 M197 M213 M196 M359 M339 M458 M
TotalLiabilitiesAndTotalEquityGrossMinorityInterest260 M285 M323 M412 M431 M457 M461 M772 M760 M904 M
TotalNonCurrentLiabilitiesNetMinorityInteres107 M113 M121 M198 M68 M182 M187 M325 M322 M301 M
TotalTaxPayable4 M2 M5 M4 M8 M
Treasury stock-259000.0-659000.0-723000.0-2 M-3 M-5 M-10 M
UnrealizedGainLoss-3 M12 M9 M
Work in progress411000.0456000.0477000.0510000.01 M361000.0886000.0652000.02 M3 M
Working capital182 M181 M71 M92 M-13 M126 M92 M234 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University